Last reviewed · How we verify
Cetrorelix Acetate, Ganerelix Acetate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Cetrorelix Acetate, Ganerelix Acetate (Cetrorelix Acetate, Ganerelix Acetate) — Assaf-Harofeh Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cetrorelix Acetate, Ganerelix Acetate TARGET | Cetrorelix Acetate, Ganerelix Acetate | Assaf-Harofeh Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cetrorelix Acetate, Ganerelix Acetate CI watch — RSS
- Cetrorelix Acetate, Ganerelix Acetate CI watch — Atom
- Cetrorelix Acetate, Ganerelix Acetate CI watch — JSON
- Cetrorelix Acetate, Ganerelix Acetate alone — RSS
Cite this brief
Drug Landscape (2026). Cetrorelix Acetate, Ganerelix Acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/cetrorelix-acetate-ganerelix-acetate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab